Home | All intervention

[RDF data]
Intervention #100401 (Drug:Olmesartan medoxomil-hydrochlorothiazide)

Resource URI: http://static.linkedct.org/resource/intervention/100401
PropertyValue
linkedct:description Olmesartan medoxomil 20 mg/hydrochlorothiazide 12.5 mg, capsules, orally, and TAK-491and chlorthalidone placebo-matching tablets, orally, once daily for 8 weeks. If participant does not achieve target blood pressure at Week 4, then the dosage will be increased to olmesartan medoxomil 40 mg/hydrochlorothiazide 25 mg, capsules, orally, once daily for the remaining 4 weeks.
is linkedct:intervention of <http://static.linkedct.org/resource/trials/NCT00846365>
linkedct:intervention_id 100401 (xsd:int)
linkedct:intervention_name Olmesartan medoxomil-hydrochlorothiazide
linkedct:intervention_type Drug
rdfs:label Intervention #100401 (Drug:Olmesartan medoxomil-hydrochlorothiazide)
rdf:type linkedct:intervention